ARTICLES

Filter  
Active filters 0
Remove
  

Refine your searches by:

Collections
Medicine / Sub specialtie
Public health
Biology
Agronomy and forestry
Pure sciences
Research
Education
Technology
Medicine / Pharmacology
Food and nutrition
all records (73)

Languages
English
Spanish
Portuguese
German
French

Countries
Indonesia
USA
Ukraine
Brazil
Poland
Pakistan
South Africa
Canada
Russia
Italy
all records (72)

Years
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
all records (24)

Filter  
 
54.587  Articles
1 of 5.460 pages  |  10  records  |  more records»
Kovbasniuk Yuriy, Plenova Olga. Anticoagulant treatment of af: focus on the warfarin dosage. Journal of Education, Health and Sport. 2015;5(10):323-326. ISSN 2391-8306. DOIhttp://dx.doi.org/10.5281/zenodo.35295http://ojs.ukw.edu.pl/index.php/johs/article/... see more

Venous thromboembolism (VTE) is a disease that includes both deep vein thrombosis (DVT) and pulmonary embolism (PE), is an important cause of morbidity and mortality worldwide. VTE is the third most common cardiovascular illness after acute coronary syndr... see more

Clinical effectiveness of the Natural Anticoagulant Sulodexide at violations in system of a hemostasis at pregnant women with threat of premature births is studied. 57 pregnant women with threat of premature births are examined. At 31 women in a combine o... see more

BACKGROUND: Pulmonary embolism and deep venous thrombosis, known as venous thromboembolism (VTE), are associated with a high proportion of morbidity and mortality.AIM: Aim of this review is to emphasise current diagnostic and therapeutic modalities for VT... see more

AIM: The study aim is to evaluate the cost-effectiveness of thrombolytic treatment in acute MI comparing with anticoagulants therapy and between each other thrombolytic (SK, r-Pa).MATERIAL AND METHODS: We used a prospective registry of all patients admitt... see more

Venous thromboembolism (VTE) complicates the clinical course of approximately 5–10% of all cancer patients. Anticoagulation of the cancer patient often presents unique challenges as these patients have both a higher risk of recurrent VTE and a higher risk... see more

Background: After revascularisation, patients with peripheral arterial disease (PAD) are routinely prescribed antiplatelet treatment (APT). Patients who receive anticoagulant treatment (ACT) due to comorbidity are an exception. We set out to determine pos... see more

Deficiency of protein C (PC), protein S (PS), antithrombin III (AT III), and homozygosity or combined heterozygosity for Factor V Leiden (FVL) and Factor II (FII) 20210A mutation represent severe hereditary thrombophilia (SHT) and are associated with a hi... see more

The coexistence of acute ischemic stroke and acute myocardial infarction is rare. The reperfusion therapy used in the therapeutic window is the golden standard in the treatment of both diseases. We present a case of successful aspiration thrombectomy circ... see more

1 of 5.460 pages  |  10  records  |  more records»